Cancer is one of the most debilitating diseases of all-time, and it has taken the lives of millions. The body’s vital organ’s are very vulnerable when it comes to dealing with this disease. For some reason, cancer tends to manifest its ugly head from numerous bodily organs such as the skin, the lungs, the breasts or the prostate. Men and women are both at risk for cancer’s wrath and there is no exception to the rule. Dr. Clay Siegall has a firm understanding of cancer, and he has been using this understanding to save people’s lives.
Siegall is the CEO and founder for one of the world’s top cancer-fighting institutions. Have you ever heard of Seattle Genetics? Seattle Genetics has pushed the boundaries of cancer research, and it has other similar companies doing the same. Though these companies are fighting for the top position, they all have the same end-goal in mind and that is to wipeout this dangerous illness. Seattle Genetics has a remarkable resume, and it has a stellar reputation. ADCETRIS, the company’s premier medication, has earned the company more than $350 million since its birth. This advanced medication is an antibody-drug conjugate. Antibody-drug conjugates are highly sophisticated in their actions. The medications are also far superior than other radical treatments like chemotherapy. Chemotherapy does a good job of killing bad cells within the body, but it also does a horrible job of killing the good cells within the body. When this action occurs, the patient can be left with a sickening-effect.
By implementing rigorous research and a plethora of scientific innovation, Seattle Genetics has been able to set itself apart from all challengers. Siegall has been the man with the plan, and his progressive leadership has helped to change cancer research’s furious landscape.